TBE-vaccine ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 46 | 悪性関節リウマチ | 1 |
46. 悪性関節リウマチ
臨床試験数 : 4,325 / 薬物数 : 2,671 - (DrugBank : 417) / 標的遺伝子数 : 187 - 標的パスウェイ数 : 224
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01131910 (ClinicalTrials.gov) | May 2010 | 24/5/2010 | TBE-vaccine to Patients With Rheumatoid Arthritis Who Are Using Immunosuppressive Drugs | Efficacy of TBE-vaccine to Patients With Rheumatic Disease Who Are Treated With Methotrexate and/or TNF-alfa Blocking Drugs | Rheumatoid Arthritis;Exposed to TBE-virus;Immunosuppression | Biological: TBE-vaccine;Biological: Vaccination against TBE | Sormland County Council, Sweden | Karolinska Institutet | Completed | 18 Years | N/A | Both | 68 | Phase 2 | Finland;Sweden |